Helicos' Q2 Grant Revenue Rises; Reagent Issues Affect Orders | GenomeWeb
This article has been updated to include comments from a conference call and an updated stock quote.
 
NEW YORK (GenomeWeb News) – Helicos BioSciences this morning reported that its grant revenues rose 75 percent for the three-month period ended June 30, while its net loss increased by 47 percent.
 
The Cambridge, Mass.-based firm brought in grant revenue of $251,000 compared to $143,000 in the second quarter of 2007. Helicos claimed no revenues from product sales during the quarter.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.